News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Snail Venom Painkiller Launched
July 10, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Prialt is a drug that harnesses the power of deadly sea snail venom has been launched in Britain.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
MORE ON THIS TOPIC
FDA
Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up
July 9, 2026
·
1 min read
·
Heather McKenzie
Complete response letters
FDA freezes CRL trove as ‘radical transparency’ push hits speedbump
July 9, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Amgen recalls almost 1 million bottles of heart failure drug over quality issue
July 8, 2026
·
1 min read
·
Nick Paul Taylor
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
July 8, 2026
·
2 min read
·
Tristan Manalac
